+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmacovigilance Market by Type (Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting), Product Life Cycle (Phase I, Phase II, Phase III), Delivery Mode, Process Flow, Therapeutic Area, End-user - Global Forecast 2025-2030- Product Image
Pharmacovigilance Market by Type (Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting), Product Life Cycle (Phase I, Phase II, Phase III), Delivery Mode, Process Flow, Therapeutic Area, End-user - Global Forecast 2025-2030- Product Image
Sale

Pharmacovigilance Market by Type (Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting), Product Life Cycle (Phase I, Phase II, Phase III), Delivery Mode, Process Flow, Therapeutic Area, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5306611
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmacovigilance market is evolving rapidly as healthcare systems worldwide intensify their focus on proactive drug safety, advanced monitoring, and regulatory compliance. Amid rising complexity in clinical data and increasing digitalization, organizations require forward-thinking strategies to manage risks and maintain patient trust.

Market Snapshot: Pharmacovigilance Market Size and Growth Outlook

The pharmacovigilance market continued its robust trajectory, with growth from USD 10.24 billion in 2024 to USD 11.84 billion in 2025. It is projected to expand at a CAGR of 15.85%, reaching USD 24.76 billion by 2030. Escalating regulatory demands, integration of real-world evidence, and innovative analytics are fueling this expansion as biopharmaceutical stakeholders prioritize safety oversight and efficient lifecycle management.

Scope & Segmentation of the Pharmacovigilance Market

This report delivers comprehensive analysis by segment and region, covering essential categories and emerging trends:

  • Type: Cohort event monitoring, EHR mining, intensified adverse drug reaction reporting, spontaneous reporting, targeted spontaneous reporting
  • Product Life Cycle: Pre-clinical, Phase I, Phase II, Phase III, Phase IV
  • Delivery Mode: In-house, outsourced
  • Process Flow: Case data analysis, case logging, medical reviewing and reporting, risk evaluation system, risk mitigation system, adverse event analysis, adverse event logging, adverse event review and reporting
  • Therapeutic Area: Cardiovascular, infectious diseases, neurology, oncology, respiratory
  • End-User: Biotechnology companies, medical device manufacturers, pharmaceutical organizations
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, United Arab Emirates, South Africa, and more), Asia-Pacific (China, India, Japan, Australia, and others)
  • Technologies: Artificial intelligence, machine learning, cloud-based platforms, blockchain, electronic health records integration
  • Leading Companies: Accenture PLC, Bristol-Myers Squibb, Capgemini SE, ClinChoice, GlaxoSmithKline PLC, HCL Technologies, ICON PLC, IQVIA Inc., Novartis AG, Oracle Corporation, Parexel International, Sanofi S.A., and others

Key Takeaways: Strategic Insights for Decision-Makers

  • Integration of AI-based analytics and electronic health record mining is accelerating the identification and mitigation of drug-related risks.
  • Collaboration between regulatory authorities and industry stakeholders is standardizing safety monitoring protocols and supporting international harmonization efforts.
  • Delivery models are shifting, with a balance between in-house and outsourced pharmacovigilance to achieve operational efficiency and specialized expertise.
  • Segment diversity across process flows and therapeutic areas reveals opportunities for tailored solutions and drives innovation in risk management practices.
  • Companies leveraging modular, cloud-native architectures and interoperable platforms are better positioned to scale safety surveillance and adapt to compliance shifts.
  • Regional variation persists, requiring flexible strategies to address local regulatory maturity, technological adoption, and resource allocation.

Tariff Impact: Navigating Changing Cost Dynamics

Newly implemented tariffs in the United States are reshaping cost structures for imported pharmacovigilance technologies and outsourced services. Stakeholders are reassessing vendor relationships, pursuing domestic partnerships, and diversifying procurement to minimize disruptions. These changes are also pushing innovation in homegrown software and analytics tools, reinforcing the need for robust compliance and resource planning across the supply chain.

Methodology & Data Sources

This report applies rigorous research standards, aggregating data from case reports, electronic health records, and expert literature. Analytical techniques include predictive modeling, disproportionality analysis, and AI-driven signal detection. Validation protocols ensure consistency, cross-referencing regulatory intelligence and upholding data privacy in compliance with global standards.

Why This Report Matters: Outcome-Driven Benefits

  • Enables senior leaders to make informed procurement and risk mitigation decisions by providing actionable intelligence on market dynamics and segmentation.
  • Equips organizations to benchmark their pharmacovigilance capabilities and align with evolving global regulations and technology trends.
  • Supports long-term strategy by detailing opportunities for innovation, operational optimization, and compliance in a highly regulated environment.

Conclusion

The pharmacovigilance market’s transformation relies on advanced analytics, global collaboration, and adaptive technology adoption. Organizations prepared to navigate evolving risks and regulatory expectations will maintain operational resilience and optimize patient safety across the product lifecycle.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence and machine learning for proactive adverse event signal detection and risk assessment
5.2. Adoption of real-world evidence derived from electronic health records and wearable tech to complement safety data
5.3. Expansion of patient-centric pharmacovigilance apps enabling direct reporting of adverse events via mobile platforms
5.4. Implementation of blockchain technologies to ensure auditability and integrity of individual case safety reports across systems
5.5. Deployment of natural language processing tools to mine social media and clinical notes for early adverse event signals
5.6. Shift towards global regulatory harmonization and data standardization under ICH E2B(R3) guidelines for cross-border safety reporting
5.7. Emergence of cloud-based safety databases with automated workflows for case intake, triage, and regulatory submission
5.8. Growth in decentralized clinical trials requiring remote pharmacovigilance monitoring and virtual patient safety assessments
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmacovigilance Market, by Type
8.1. Introduction
8.2. Cohort Event Monitoring
8.3. EHR Mining
8.4. Intensified ADR Reporting
8.5. Spontaneous Reporting
8.6. Targeted Spontaneous Reporting
9. Pharmacovigilance Market, by Product Life Cycle
9.1. Introduction
9.2. Phase I
9.3. Phase II
9.4. Phase III
9.5. Phase IV
9.6. Pre-clinical
10. Pharmacovigilance Market, by Delivery Mode
10.1. Introduction
10.2. In-house
10.3. Outsourced
11. Pharmacovigilance Market, by Process Flow
11.1. Introduction
11.2. Case Data Management
11.2.1. Case Data Analysis
11.2.2. Case Logging
11.2.3. Medical Reviewing & Reporting
11.3. Risk Management System
11.3.1. Risk Evaluation System
11.3.2. Risk Mitigation System
11.4. Signal Detection
11.4.1. Adverse Event Analysis
11.4.2. Adverse Event Logging
11.4.3. Adverse Event Review & Reporting
12. Pharmacovigilance Market, by Therapeutic Area
12.1. Introduction
12.2. Cardiovascular
12.3. Infectious Diseases
12.4. Neurology
12.5. Oncology
12.6. Respiratory
13. Pharmacovigilance Market, by End-user
13.1. Introduction
13.2. Biotechnology Companies
13.3. Medical Device Manufacturers
13.4. Pharmaceuticals
14. Americas Pharmacovigilance Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Pharmacovigilance Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Pharmacovigilance Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Accenture, PLC
17.3.2. Bristol-Myers Squibb Company
17.3.3. Capgemini SE
17.3.4. ClinChoice
17.3.5. F. Hoffmann-La Roche AG
17.3.6. GlaxoSmithKline PLC
17.3.7. HCL Technologies Limited
17.3.8. ICON PLC
17.3.9. Infosys Limited
17.3.10. International Business Machines Corporation
17.3.11. IQVIA Inc.
17.3.12. ITclinical
17.3.13. Laboratory Corporation of America Holdings
17.3.14. Linical Co., Ltd.
17.3.15. Novartis AG
17.3.16. Oracle Corporation
17.3.17. Parexel International
17.3.18. Pfizer Inc.
17.3.19. Quanticate International limited
17.3.20. Sanofi S.A.
17.3.21. Syneos Health
17.3.22. TAKE Solutions Limited
17.3.23. TATA Consultancy Services Limited
17.3.24. Wipro Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. PHARMACOVIGILANCE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACOVIGILANCE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PHARMACOVIGILANCE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PHARMACOVIGILANCE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. PHARMACOVIGILANCE MARKET: RESEARCHAI
FIGURE 28. PHARMACOVIGILANCE MARKET: RESEARCHSTATISTICS
FIGURE 29. PHARMACOVIGILANCE MARKET: RESEARCHCONTACTS
FIGURE 30. PHARMACOVIGILANCE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHARMACOVIGILANCE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACOVIGILANCE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHARMACOVIGILANCE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY COHORT EVENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY COHORT EVENT MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY EHR MINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY EHR MINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY INTENSIFIED ADR REPORTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY INTENSIFIED ADR REPORTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY SPONTANEOUS REPORTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY SPONTANEOUS REPORTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TARGETED SPONTANEOUS REPORTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TARGETED SPONTANEOUS REPORTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY IN-HOUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY OUTSOURCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CASE LOGGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CASE LOGGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY MEDICAL REVIEWING & REPORTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY MEDICAL REVIEWING & REPORTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY RISK EVALUATION SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY RISK EVALUATION SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY RISK MITIGATION SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY RISK MITIGATION SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ADVERSE EVENT ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ADVERSE EVENT ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ADVERSE EVENT LOGGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ADVERSE EVENT LOGGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ADVERSE EVENT REVIEW & REPORTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ADVERSE EVENT REVIEW & REPORTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY RESPIRATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 132. CANADA PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 133. CANADA PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 134. CANADA PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 135. CANADA PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 136. CANADA PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 137. CANADA PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 138. CANADA PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 139. CANADA PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 140. CANADA PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 141. CANADA PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 142. CANADA PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 143. CANADA PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 144. CANADA PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 145. CANADA PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 146. CANADA PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 147. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 154. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 155. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 156. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 157. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 158. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 159. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 162. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 163. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 164. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 239. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 246. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 247. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 248. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 249. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 250. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 251. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 252. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 254. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 255. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 256. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 257. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 262. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 263. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 264. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 265. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 266. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 267. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 268. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 269. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 272. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 273. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 274. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 293. ITALY PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 294. ITALY PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295. ITALY PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 296. ITALY PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 297. ITALY PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 298. ITALY PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 299. ITALY PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 300. ITALY PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 301. ITALY PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 302. ITALY PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 303. ITALY PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 304. ITALY PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 305. ITALY PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 306. ITALY PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 307. ITALY PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 308. ITALY PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 309. ITALY PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 310. ITALY PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 311. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 312. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 313. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 314. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 315. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 316. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 317. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 318. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 319. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 320. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 321. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2018-2024 (USD MILLION)
TABLE 322. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY RISK MANAGEMENT SYSTEM, 2025-2030 (USD MILLION)
TABLE 323. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 324. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 325. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 326. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 327. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 328. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, BY PRODUCT LIFE CYCLE, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, BY PROCESS FLOW, 2025-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET SIZE, BY CASE DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES PHARMACOVIGILANCE MARKET S

Samples

Loading
LOADING...

Companies Mentioned

  • Accenture, PLC
  • Bristol-Myers Squibb Company
  • Capgemini SE
  • ClinChoice
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • HCL Technologies Limited
  • ICON PLC
  • Infosys Limited
  • International Business Machines Corporation
  • IQVIA Inc.
  • ITclinical
  • Laboratory Corporation of America Holdings
  • Linical Co., Ltd.
  • Novartis AG
  • Oracle Corporation
  • Parexel International
  • Pfizer Inc.
  • Quanticate International limited
  • Sanofi S.A.
  • Syneos Health
  • TAKE Solutions Limited
  • TATA Consultancy Services Limited
  • Wipro Limited

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 24.76 Billion
Compound Annual Growth Rate15.8%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Clinical Safety & Pharmacovigilance Services Market by Service Type, End User, Clinical Trial Phase, Therapeutic Area, Deployment Mode - Global Forecast 2025-2030 - Product Image

Clinical Safety & Pharmacovigilance Services Market by Service Type, End User, Clinical Trial Phase, Therapeutic Area, Deployment Mode - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Pharmacovigilance & Drug Safety Software Market by Component (Pharmacovigilance Analytics, Regulatory Reporting, Safety Database Management), Organization Size (Large Enterprise, Small And Medium Enterprise), End User, Deployment Mode, Application - Global Forecast 2025-2030 - Product Image

Pharmacovigilance & Drug Safety Software Market by Component (Pharmacovigilance Analytics, Regulatory Reporting, Safety Database Management), Organization Size (Large Enterprise, Small And Medium Enterprise), End User, Deployment Mode, Application - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Pharmacovigilance Market Size, Share & Trends Analysis Report By Product Life Cycle, By Service Provider (In-house, Contract Outsourcing), By Type, By Therapeutic Area, By Process Flow, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Pharmacovigilance Market Size, Share & Trends Analysis Report By Product Life Cycle, By Service Provider (In-house, Contract Outsourcing), By Type, By Therapeutic Area, By Process Flow, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Pharmacovigilance and Drug Safety Software Market Report by Functionality, Delivery Mode, End User, and Region 2025-2033 - Product Image

Pharmacovigilance and Drug Safety Software Market Report by Functionality, Delivery Mode, End User, and Region 2025-2033

  • Report
  • 134 Pages
  • Global
From
Post-Marketing Pharmacovigilance and Medical Information - Global Strategic Business Report - Product Image

Post-Marketing Pharmacovigilance and Medical Information - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From

About the Pharmacovigilance Market

The Pharmacovigilance market is a subset of the Healthcare Services industry, focusing on the monitoring and assessment of the safety of pharmaceutical products. It involves the collection, analysis, and reporting of adverse events related to the use of drugs, as well as the identification of potential risks associated with their use. Pharmacovigilance activities are conducted by pharmaceutical companies, regulatory authorities, and healthcare professionals. Pharmacovigilance activities are essential for the safe and effective use of drugs, as they help to identify potential risks and ensure that the benefits of the drug outweigh the risks. Pharmacovigilance also helps to ensure that the drug is used appropriately and that any adverse events are reported and addressed. Some companies in the Pharmacovigilance market include Parexel, Quintiles, Covance, PRA Health Sciences, and ICON. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.